Investor mix
5 investors on record; lead investors include F-Prime Capital, Orbimed; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Private equity | 1 | 20% |
Provider of therapies for rare genetic diseases
5 investors on record; lead investors include F-Prime Capital, Orbimed; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Private equity | 1 | 20% |